We are live on
!
Find out more
FI
Focused Investors Portfolio holdings
AUM
$2.96B
1-Year Est. Return
15.6%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+15.6%
3 Year Est. Return
+51.26%
5 Year Est. Return
+77.43%
10 Year Est. Return
+309.27%
AUM
$2.54B
AUM Growth
-$61.9M
(-2.4%)
Cap. Flow
-$52M
Cap. Flow
% of AUM
-2.05%
Top 10 Holdings %
Top 10 Hldgs %
55.94%
Holding
24
New
–
Increased
2
Reduced
21
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$28.3M |
| 2 |
Morgan Stanley
MS
|
+$6.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$48M |
| 2 |
Microsoft
MSFT
|
+$2.73M |
| 3 |
CVS Health
CVS
|
+$2.73M |
| 4 |
Target
TGT
|
+$2.57M |
| 5 |
Johnson & Johnson
JNJ
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.71% |
| 2 | Consumer Staples | 23.14% |
| 3 | Financials | 22.07% |
| 4 | Technology | 11.42% |
| 5 | Industrials | 10.87% |
Similar funds
SSM
VGM
CSIC
BCF
PHAM
SP
B
NC
Focused Investors's Q2 2016 Portfolio in Review
As of Q2 2016, Focused Investors held 24 positions worth $2.54B, down 2.4% from $2.6B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Trading was light in Q2 2016: portfolio turnover was 4.2%. Focused Investors opened no new positions and exited 1, leaving the 24-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Consumer Staples and Financials.
- Focused Investors added most to Elevance Health in Q2 2016, an estimated $28.3M increase.
- Focused Investors's biggest Q2 2016 reduction was Microsoft, cutting an estimated $2.73M.
- Focused Investors fully exited Procter & Gamble in Q2 2016, selling an estimated $48M.
- Focused Investors's ten largest holdings make up 56% of its $2.54B portfolio in Q2 2016.
- Focused Investors opened 0 new positions and closed 1 in Q2 2016.
- Focused Investors's portfolio value fell 2.4% quarter-over-quarter to $2.54B.
Based on Focused Investors's 13F filing for Q2 2016, filed 21 Jul 2016.